A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
Clinical trial NCT04159779 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04159779
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-13
- Primary completion
- 2026-06-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.